Imunon Inc.

IMNN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.43

+$0.07 (+5.15%)

At close: Sep 21, 2026, 4:00 PM ET

$1.44

+$0.01 (+0.70%)

Pre-market: Sep 22, 2026, 8:35 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.15%

(1D)

Rating

Updated: Sep 8, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $6.01M

1D Range

1.36 1.47

52W Range

1.33 5.64

Valuation (TTM)

PE -0.32

PB 1.43

EV/EBITDA -0.50

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $10

Cash Flow

FCF Yield -67762.8%

SBC Adj. FCF Yield -69315.4%

SBC Impact -2.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -83.3%

Dil EPS 3Y | 5Y 71.4% | 47.0%

FCF 3Y | 5Y -148.1% | -97.5%

Returns

ROA -98.2%

ROE -314.9%

ROIC -122.2%

Financial Health

Net Debt

$169.72K

Current Ratio 1.82

Interest Coverage -191.99

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline fe...

Sector Healthcare

Industry Biotechnology

Employees 20

IPO Date Feb 28, 1999

Website www.imunon.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.